Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial.
Lu CL, Yang LQ, Jin XY, Friedemann T, Li YF, Liu XH, Chen XY, Zou XY, Zhang BR, Wang FX, Lin YL, Tang YM, Cao ML, Jiang YL, Gao YF, Liu K, Tao ZG, Robinson N, Schröder S, Liu JP, Lu HZ.
Lu CL, et al. Among authors: zou xy.
Front Pharmacol. 2024 May 27;15:1383831. doi: 10.3389/fphar.2024.1383831. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38863976
Free PMC article.